SHIFT (Completed) Systolic Heart failure treatment with the If inhibitor ivabradine Trial Medicine ivabradine Population Heart failure Phase III Starting year 2006 Director of Study dr. T. Lenderink (Cardioloog) Sittard-Geleen, Zuyderland Medisch Centrum